254 related articles for article (PubMed ID: 27857060)
1. Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysis.
Yang L; Feng S; Yang Y
Cancer Gene Ther; 2016 Dec; 23(12):439-445. PubMed ID: 27857060
[TBL] [Abstract][Full Text] [Related]
2. Identification of upstream transcription factors (TFs) for expression signature genes in breast cancer.
Zang H; Li N; Pan Y; Hao J
Gynecol Endocrinol; 2017 Mar; 33(3):193-198. PubMed ID: 27809618
[TBL] [Abstract][Full Text] [Related]
3. Cholangiocarcinoma‑associated genes identified by integrative analysis of gene expression data.
Zhong W; Dai L; Liu J; Zhou S
Mol Med Rep; 2018 Apr; 17(4):5744-5753. PubMed ID: 29436659
[TBL] [Abstract][Full Text] [Related]
4. Identification of biomarkers of intrahepatic cholangiocarcinoma via integrated analysis of mRNA and miRNA microarray data.
Chen Y; Liu D; Liu P; Chen Y; Yu H; Zhang Q
Mol Med Rep; 2017 Mar; 15(3):1051-1056. PubMed ID: 28098904
[TBL] [Abstract][Full Text] [Related]
5. Identification of upstream regulators for synovial expression signature genes in osteoarthritis.
Fei Q; Lin J; Meng H; Wang B; Yang Y; Wang Q; Su N; Li J; Li D
Joint Bone Spine; 2016 Oct; 83(5):545-51. PubMed ID: 26832188
[TBL] [Abstract][Full Text] [Related]
6. Integrative Analysis of Microarray Data to Reveal Regulation Patterns in the Pathogenesis of Hepatocellular Carcinoma.
Chen J; Qian Z; Li F; Li J; Lu Y
Gut Liver; 2017 Jan; 11(1):112-120. PubMed ID: 27458175
[TBL] [Abstract][Full Text] [Related]
7. Identification of differentially expressed genes regulated by transcription factors in glioblastomas by bioinformatics analysis.
Wei B; Wang L; Du C; Hu G; Wang L; Jin Y; Kong D
Mol Med Rep; 2015 Apr; 11(4):2548-54. PubMed ID: 25514975
[TBL] [Abstract][Full Text] [Related]
8. Survival analysis of genome-wide profiles coupled with Connectivity Map database mining to identify potential therapeutic targets for cholangiocarcinoma.
Lin P; Zhong XZ; Wang XD; Li JJ; Zhao RQ; He Y; Jiang YQ; Huang XW; Chen G; He Y; Yang H
Oncol Rep; 2018 Dec; 40(6):3189-3198. PubMed ID: 30272356
[TBL] [Abstract][Full Text] [Related]
9. Screening of potential biomarkers for cholangiocarcinoma by integrated analysis of microarray data sets.
Huang QX; Cui JY; Ma H; Jia XM; Huang FL; Jiang LX
Cancer Gene Ther; 2016; 23(2-3):48-53. PubMed ID: 26679756
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
Likhitrattanapisal S; Tipanee J; Janvilisri T
Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis reveals candidate genes and transcription factors in lung adenocarcinoma.
Chen B; Gao S; Ji C; Song G
Mol Med Rep; 2017 Dec; 16(6):8371-8379. PubMed ID: 28983631
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of miR‑132‑3p in cholangiocarcinoma tissues: A study based on RT‑qPCR, The Cancer Genome Atlas miRNA sequencing, Gene Expression Omnibus microarray data and bioinformatics analyses.
Wu HY; Xia S; Liu AG; Wei MD; Chen ZB; Li YX; He Y; Liao MJ; Hu QP; Pan SL
Mol Med Rep; 2019 Dec; 20(6):5002-5020. PubMed ID: 31638221
[TBL] [Abstract][Full Text] [Related]
13. Identification of hub genes and pathways in cholangiocarcinoma by coexpression analysis.
Kong J; Shen S; Zhang Z; Wang W
Cancer Biomark; 2020; 27(4):505-517. PubMed ID: 32116234
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional landscape of cholangiocarcinoma revealed by weighted gene coexpression network analysis.
Long J; Huang S; Bai Y; Mao J; Wang A; Lin Y; Yang X; Wang D; Lin J; Bian J; Yang X; Sang X; Wang X; Zhao H
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33051665
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma.
Li H; Long J; Xie F; Kang K; Shi Y; Xu W; Wu X; Lin J; Xu H; Du S; Xu Y; Zhao H; Zheng Y; Gu J
Oncol Rep; 2019 Nov; 42(5):1833-1842. PubMed ID: 31545466
[TBL] [Abstract][Full Text] [Related]
16. Integrative In Silico and In Vitro Transcriptomics Analysis Revealed Gene Expression Changes and Oncogenic Features of Normal Cholangiocytes after Chronic Alcohol Exposure.
Chujan S; Suriyo T; Satayavivad J
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795085
[TBL] [Abstract][Full Text] [Related]
17. Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma.
Chen MH; Lin KJ; Yang WL; Kao YW; Chen TW; Chao SC; Chang PM; Liu CY; Tzeng CH; Chao Y; Chen MH; Yeh CN; Huang CY
Cancer; 2013 Jan; 119(2):293-303. PubMed ID: 22810956
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of Novel Biomarkers and Potential Targeted Drugs in Cholangiocarcinoma: Bioinformatics, Virtual Screening, and Biological Evaluation.
Wang J; Zhu W; Tu J; Zheng Y
J Microbiol Biotechnol; 2022 Oct; 32(10):1262-1274. PubMed ID: 36224755
[TBL] [Abstract][Full Text] [Related]
19. ZHX1 Promotes the Proliferation, Migration and Invasion of Cholangiocarcinoma Cells.
Kwon RJ; Han ME; Kim JY; Liu L; Kim YH; Jung JS; Oh SO
PLoS One; 2016; 11(11):e0165516. PubMed ID: 27835650
[TBL] [Abstract][Full Text] [Related]
20. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
